Investing

Simulations Plus : SLP

SLP

Stock Data

$18.34

$0.07 (0.38%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

HEALTH INFORMATION SERVICES

Simulations Plus Inc specializes in advanced software for drug discovery and development. With a focus on artificial intelligence and machine learning, it offers tools like GastroPlus for simulating drug absorption and interactions. Its portfolio also includes DDDPlus, MembranePlus, and a suite of mechanistic models such as DILIsym and NAFLDsym. Beyond software, Simulations Plus provides consulting in pharmacokinetics and regulatory submissions, serving industries from pharmaceuticals to cosmetics. Founded in 1996 and based in Lancaster, California, it's a key player in supporting the lifecycle of drug development.